Gunze Ltd. (TYO:3002) is looking to launch a full-scale business for regenerative medicine products based on bioabsorbable materials. For its…...
Please subscribe to read the full story.
Pharma
Tokyo Institute of Technology, Kanto Chemical Develop Growth Medium for iPS Cell-Derived Small Intestine Models
Kanto Chemical Co. Inc. has formed a research team with Shoen Kume, a professor at the Tokyo Institute of Technology’s…...
Please subscribe to read the full story.
Column: COVID-19 Brings Major Changes to Vaccine Development
An initial batch of companies is now heading into final development for COVID-19 vaccines, with supply expected to begin this…...
Please subscribe to read the full story.
